Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic Dermatitis

ClinicalTrials.gov ID: NCT00703573

Public ClinicalTrials.gov record NCT00703573. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 29, 2026, 2:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of 2 Doses of S-777469 (400 mg BID and 800 mg BID) in Patients With Atopic Dermatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and efficacy of 2 doses of S-777469 in patients with atopic dermatitis.

Study identification

NCT ID
NCT00703573
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Shionogi
Industry
Enrollment
209 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2008
Primary completion
Apr 30, 2009
Completion
Nov 30, 2009
Last update posted
May 7, 2018

2008 – 2009

United States locations

U.S. sites
33
U.S. states
19
U.S. cities
31
Facility City State ZIP Site status
Not listed Hot Springs Arkansas 71913 —
Not listed Los Angeles California 90045 —
Not listed Oceanside California 92056 —
Not listed Riverside California 92506 —
Not listed Denver Colorado 80210 —
Not listed Coral Gables Florida 33134 —
Not listed West Palm Beach Florida 33401 —
Not listed Alpharetta Georgia 30022 —
Not listed Boise Idaho 83704 —
Not listed Arlington Heights Illinois 60005 —
Not listed Evansville Indiana 47713 —
Not listed South Bend Indiana 46617 —
Not listed Fridley Minnesota 55432 —
Not listed Omaha Nebraska 68144 —
Not listed Berlin New Jersey 08009 —
Not listed Paramus New Jersey 07652 —
Not listed Stony Brook New York 11790 —
Not listed Lake Oswego Oregon 97035 —
Not listed Portland Oregon 97210 —
Not listed Portland Oregon 97223 —
Not listed Portland Oregon 973239 —
Not listed Philadelphia Pennsylvania 19104 —
Not listed Johnston Rhode Island 02919 —
Not listed Goodlettsville Tennessee 37072 —
Not listed Knoxville Tennessee 37934 —
Not listed Austin Texas 78759 —
Not listed College Station Texas 77845 —
Not listed Dallas Texas 75230 —
Not listed Houston Texas 77058 —
Not listed San Antonio Texas 78229 —
Not listed West Jordan Utah 84088 —
Not listed Lynchburg Virginia 24501 —
Not listed Norfolk Virginia 23507 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00703573, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 7, 2018 · Synced Sep 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00703573 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →